{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:46Z","timestamp":1747224526744,"version":"3.40.5"},"reference-count":9,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>Primary and booster vaccines for COVID-19 are the most effective method of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date there have been seven reported cases of Sweet syndrome occurring following the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine.<\/jats:p>","DOI":"10.4081\/dr.2023.9668","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T09:08:35Z","timestamp":1684832915000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent giant cellulitis-like sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine"],"prefix":"10.4081","author":[{"given":"Penelope","family":"Hirt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7465-5224","authenticated-orcid":false,"given":"Lily","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-4588","authenticated-orcid":false,"given":"Carly E.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Kerdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"10774","doi-asserted-by":"crossref","unstructured":"Rochet NM, Chavan RN, Cappel MA, et al. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557-64.","DOI":"10.1016\/j.jaad.2013.06.023"},{"key":"10775","doi-asserted-by":"crossref","unstructured":"Nelson CA, Stephen S, Ashchyan HJ, et al. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Beh\u00e7et disease. J Am Acad Dermatol. 2018;79:987-1006.","DOI":"10.1016\/j.jaad.2017.11.064"},{"key":"10776","doi-asserted-by":"crossref","unstructured":"Darrigade AS, Th\u00e9ophile H, Sanchez-Pena P, et al. Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine. Allergy. 2021;76:3194-3196.","DOI":"10.1111\/all.14981"},{"key":"10777","doi-asserted-by":"crossref","unstructured":"Baffa ME, Maglie R, Giovannozzi N, et al. Sweet syndrome following SARS-CoV2 Vaccination. Vaccines (Basel). 2021;9:1212.","DOI":"10.3390\/vaccines9111212"},{"key":"10778","doi-asserted-by":"crossref","unstructured":"Majid I, Mearaj S. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female. Dermatol Ther. 2021;34:e15146.","DOI":"10.1111\/dth.15146"},{"key":"10779","unstructured":"Ben Rejeb S, Beltaifa D, Dhaoui A, et al. SARS-CoV-2 vaccine induced Sweet syndrome : a case report. Tunis Med. 2021;99:1188-1191."},{"key":"10780","doi-asserted-by":"crossref","unstructured":"Torrealba-Acosta G, Martin JC, Huttenbach Y, et al. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021;14:e243173.","DOI":"10.1136\/bcr-2021-243173"},{"key":"10781","doi-asserted-by":"crossref","unstructured":"Hoshina D, Orita A. Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review. J Dermatol. 2022;49:e175-e176.","DOI":"10.1111\/1346-8138.16309"},{"key":"10782","doi-asserted-by":"crossref","unstructured":"Pelchat F, Fournier C, Perron E, et al. Sweet syndrome following Moderna COVID-19 vaccine: A case report. SAGE Open Med Case Rep. 2022;10:2050313X221117884.","DOI":"10.1177\/2050313X221117884"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9668\/9095","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9668\/9095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T09:08:50Z","timestamp":1684832930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/view\/9668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.4081\/dr.2023.9668","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"type":"electronic","value":"2036-7406"},{"type":"print","value":"2036-7392"}],"subject":[],"published":{"date-parts":[[2023,5,23]]}}}